JP2022521787A5 - - Google Patents

Info

Publication number
JP2022521787A5
JP2022521787A5 JP2021549970A JP2021549970A JP2022521787A5 JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5 JP 2021549970 A JP2021549970 A JP 2021549970A JP 2021549970 A JP2021549970 A JP 2021549970A JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5
Authority
JP
Japan
Application number
JP2021549970A
Other languages
Japanese (ja)
Other versions
JPWO2020176740A5 (https=
JP2022521787A (ja
Filing date
Publication date
Priority claimed from US16/288,052 external-priority patent/US20200224160A1/en
Application filed filed Critical
Publication of JP2022521787A publication Critical patent/JP2022521787A/ja
Publication of JPWO2020176740A5 publication Critical patent/JPWO2020176740A5/ja
Publication of JP2022521787A5 publication Critical patent/JP2022521787A5/ja
Priority to JP2024219750A priority Critical patent/JP2025061660A/ja
Ceased legal-status Critical Current

Links

JP2021549970A 2018-02-27 2020-02-27 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法 Ceased JP2022521787A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024219750A JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862635702P 2018-02-27 2018-02-27
US16/288,052 2019-02-27
US16/288,052 US20200224160A1 (en) 2018-02-27 2019-02-27 Process for dna integration using rna-guided endonucleases
PCT/US2020/020121 WO2020176740A1 (en) 2018-02-27 2020-02-27 Improved process for dna integration using rna-guided endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024219750A Division JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Publications (3)

Publication Number Publication Date
JP2022521787A JP2022521787A (ja) 2022-04-12
JPWO2020176740A5 JPWO2020176740A5 (https=) 2023-03-07
JP2022521787A5 true JP2022521787A5 (https=) 2023-03-07

Family

ID=71516309

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549970A Ceased JP2022521787A (ja) 2018-02-27 2020-02-27 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Country Status (11)

Country Link
US (2) US20200224160A1 (https=)
EP (1) EP3931322A1 (https=)
JP (2) JP2022521787A (https=)
KR (1) KR20210134000A (https=)
CN (1) CN113906136A (https=)
AU (1) AU2020229848A1 (https=)
CA (1) CA3131588A1 (https=)
IL (1) IL285842A (https=)
MX (1) MX2021010322A (https=)
SG (1) SG11202109332RA (https=)
WO (1) WO2020176740A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
KR20200124702A (ko) 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
US12365888B2 (en) 2018-12-14 2025-07-22 Pioneer Hi-Bred International, Inc. CRISPR-Cas systems for genome editing
SG11202109163YA (en) * 2019-02-26 2021-09-29 Sorrento Therapeutics Inc Antigen binding proteins that bind bcma
AU2020232691B2 (en) 2019-03-05 2023-06-29 Nkarta, Inc. CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
PH12021553076A1 (en) 2019-06-07 2023-08-14 Scribe Therapeutics Inc Engineered casx systems
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
WO2022015956A1 (en) 2020-07-15 2022-01-20 Sorrento Therapeutics, Inc. Improved process for dna integration using rna-guided endonucleases
EP4192941A1 (en) * 2020-08-07 2023-06-14 Neogene Therapeutics B.V. Methods to enrich genetically engineered t cells
CN116829707A (zh) * 2020-11-11 2023-09-29 孟山都技术公司 提高定点整合频率的方法
AU2021392719B2 (en) 2020-12-03 2025-08-14 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
WO2022215978A1 (ko) * 2021-04-05 2022-10-13 주식회사 셀렌진 Pdcd-1 유전자에 상보적인 가이드 rna 및 이의 용도
WO2026020171A2 (en) 2024-07-19 2026-01-22 Aera Therapeutics, Inc. Chimeric antigen receptor constructs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010907A (en) * 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6556674B1 (en) 1998-11-19 2003-04-29 Legerity, Inc. Signal detector with matched filter coefficient
US9957515B2 (en) * 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
WO2014191128A1 (en) * 2013-05-29 2014-12-04 Cellectis Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
WO2017070429A1 (en) * 2015-10-22 2017-04-27 Regents Of The University Of Minnesota Methods involving editing polynucleotides that encode t cell receptor
US11377637B2 (en) * 2016-04-15 2022-07-05 Memorial Sloan Kettering Cancer Center Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
EP4674970A3 (en) * 2016-05-27 2026-03-18 Life Technologies Corporation Compositions and methods for enhancing homologous recombination
WO2018023631A1 (zh) * 2016-08-04 2018-02-08 汤隆初 自动浇水技术的使用情况反馈方法以及自动浇水装置
WO2018073391A1 (en) * 2016-10-19 2018-04-26 Cellectis Targeted gene insertion for improved immune cells therapy
US20200299729A1 (en) * 2017-09-08 2020-09-24 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
WO2019204226A1 (en) * 2018-04-16 2019-10-24 University Of Massachusetts Compositions and methods for improved gene editing

Similar Documents

Publication Publication Date Title
JP2022521787A5 (https=)
CN305531051S (https=)
CN305530727S (https=)
CN305536812S (https=)
CN305536626S (https=)
CN305536202S (https=)
CN305536170S (https=)
CN305536169S (https=)
CN305536103S (https=)
CN305535738S (https=)
CN305533975S (https=)
CN305533459S (https=)
CN305531344S (https=)
CN305530810S (https=)
CN305530312S (https=)
CN305528841S (https=)
CN305527733S (https=)
CN305527245S (https=)
CN305526790S (https=)
CN306115820S (https=)
CN306114848S (https=)
CN305741391S (https=)
CN306113495S (https=)
CN306111041S (https=)
CN306108299S (https=)